Stryker Brain Stent Limited to Certain Patients by FDA

Stryker Corp.’s Wingspan brain stent will be limited to use by a smaller group of patients than U.S. regulators initially approved and the device will now require post-market monitoring, U.S. regulators said.
Bloomberg